Szkultecka-Dębek, M. (2013) “Adverse events (AE) costs assessed in Poland based on existing Drug Programs – methodology of the project”, Current Issues in Pharmacy and Medical Sciences, 26(4), pp. 422–424. doi:10.12923/j.2084-980X/26.4/a.16.